New treatments for rare tumors
Treatments studied
Part of Cancer clinical trials.
This trial tests new experimental cancer treatments and technologies for people with rare or hard-to-treat tumors. It aims to find tailored therapies that may work better for your specific cancer. You will be asked to provide a tumor sample for testing, and the trial team will guide you through the process.
Summary written for real people, not researchers, by Clin2.
Who can take part
- A diagnosis of cancer confirmed by biopsy or other lab test
- Age 16 or older
- Able to carry out daily activities with some help (ECOG performance status 0-2)
- Provide a fresh tumor sample (biopsy) or old stored tumor tissue, plus a blood sample
- Recover from side effects of previous cancer treatments
- Agree to use effective birth control during the study and for 8 weeks after
- No serious heart, lung, or other uncontrolled medical conditions
- Not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized treatment that uses your own immune cells, modified to recognize and attack your cancer. It may help people with advanced solid tumors who have not improved with standard treatments.
This trial tests a personalized treatment that uses your own immune cells, specially trained to find and attack your tumor. It is for people with advanced solid tumors that have not responded to standard treatments.
This trial tests a personalized approach for people with rare advanced or metastatic solid tumors. Doctors use special lab tests on your tumor tissue and blood to find the best treatment for you.
This study tests targeted drugs or immunotherapy based on the genetic features of your tumor. It may help people with rare, advanced cancers whose disease has progressed after standard treatment options.
This trial tests a personalized treatment made from your own immune cells to fight advanced solid tumors that have not responded to standard treatments. If you qualify, the treatment is created specifically for your tumor, which may help your body attack the cancer more effectively.
This trial tests two experimental drugs given together to treat advanced solid tumors that have not responded to previous treatments. The goal is to see if the combination helps shrink or control the cancer, and the study is for people who are otherwise in fairly good health.
Hear when a new Rare Malignant Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.